Yu Bai, MD
Clinical Pathology/Laboratory Medicine · Houston, TXNPI 1578684254
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $530 of the $822 with a category attached, or 64.5%. 11 manufacturers reported payments, led by Sanofi at 59.6% of the total. Reporting peaked in 2024 at $428 and has fallen 76.8% since, to $99 in 2025.
Across 18 payments — averaging $45.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$490
- Janssen Scientific Affairs, LLC$99
- AstraZeneca$54
- Amgen$44
- Ortho-clinical Diagnostics, Inc.$33
- Spectrum Pharmaceuticals Inc.$22
- plus $80 from 5 others
What the payments were for
- Consulting fees$25030%
- Food & beverage$53064%
- Education$425%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 5 | $490 |
| Janssen Scientific Affairs, LLC | 1 | $99 |
| AstraZeneca | 3 | $54 |
| Amgen | 2 | $44 |
| Ortho-clinical Diagnostics, Inc. | 1 | $33 |
| Spectrum Pharmaceuticals Inc. | 1 | $22 |
| Incyte Corporation | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Rigel Pharmaceuticals, Inc. | 1 | $16 |
| Agios Pharmaceuticals, Inc. | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CABLIVI$144
How this compares
$822 in reported general payments places this provider in the 65th percentile of 31 clinical pathology/laboratory medicine providers in Texas.
See all clinical pathology/laboratory medicine providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other clinical pathology/laboratory medicine in Houston
- Dipen MaruHouston$6K
- Martin MatzukHouston$2K
- Jing LiuHouston$2K
- Wei FengHouston$726
- Elizabeth HartwellHouston$631
- Christie FinchHouston$186
- Alice ChenHouston$143
- Christopher LevequeHouston$132
- Nghia NguyenHouston$83
- Norma QuintanillaHouston$67
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.